Protalix Bio Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Protalix Bio Therapeutics ( PLX) is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. This stock is trading up 3% to $6.43 in recent trading.

Today's Range: $6.29-$6.46

52-Week Range: $4.06-$7.16

Volume: 319,000

Three-Month Average Volume: 347,900

From a technical perspective, PLX is gapping up notably higher today on decent volume. This move is quickly pushing the stock within range of triggering a major breakout trade. That trade will hit once PLX takes out some past overheard resistance at $6.70 to $7.28 with high-volume.

Traders should now look for long-biased trades in PLX if it can sustain a move or close above those levels with volume that's near or well above 347,900 shares. If we get that action soon, look for PLX to make a run at its next significant overhead resistance level of $10.

To see more stocks under-$10 that are making notable moves higher today, check out the Stocks Under-$10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.


Follow Stockpickr on Twitter and become a fan on Facebook.
At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on stocks, options, futures, commodities and currencies. He is also an outside contributor to and maintains the website, which he sold to Blue Wave Advisors in 2008. Roberto studied International Business at The Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany.

If you liked this article you might like

SEC Takes On Ironridge Global Partners Over Deals Based on Buying Microcap Bills From Creditors

A Few Tricks and Treats

A Few Tricks and Treats

Why NewLead Holdings (NEWL) Stock Is Tanking In After-Hours Trading On Wednesday

Why NewLead (NEWL) Stock Is Soaring Today

NewLead Holdings (NEWL) Stock Continues to Plunge (Update)